A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation
about
Evolutionary history and attenuation of myxoma virus on two continentsA Shope Fibroma virus PYRIN-only protein modulates the host immune responseMyxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1Poxviral ankyrin proteinsPoxvirus tropismCo-regulation of NF-kappaB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013A novel inhibitor of the NF-{kappa}B signaling pathway encoded by the parapoxvirus orf virusInhibiting NF-κB activation by small molecules as a therapeutic strategy.The MC160 protein expressed by the dermatotropic poxvirus molluscum contagiosum virus prevents tumor necrosis factor alpha-induced NF-kappaB activation via inhibition of I kappa kinase complex formation.A nuclear inhibitor of NF-kappaB encoded by a poxvirus.Orf virus ORFV121 encodes a novel inhibitor of NF-kappaB that contributes to virus virulenceVaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.Genomic sequence and analysis of a vaccinia virus isolate from a patient with a smallpox vaccine-related complicationMyxoma virus and the Leporipoxviruses: an evolutionary paradigm.Genetic Variability of Myxoma Virus Genomes.The Role of F-Box Proteins during Viral Infection.Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexesPoxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function.M148R and M149R are two virulence factors for myxoma virus pathogenesis in the European rabbitInterplay between poxviruses and the cellular ubiquitin/ubiquitin-like pathways.Functional diversity of ankyrin repeats in microbial proteins.The current status and future directions of myxoma virus, a master in immune evasion.Poxvirus exploitation of the ubiquitin-proteasome system.Viral interference with innate immunity by preventing NF-κB activity.Therapeutic immunomodulation using a virus--the potential of inactivated orf virus.Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation.Hepatitis C virus and host cell nuclear transport machinery: a clandestine affair.Merkel cell polyomavirus small T antigen targets the NEMO adaptor protein to disrupt inflammatory signalingMNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection.The myxoma virus m-t5 ankyrin repeat host range protein is a novel adaptor that coordinately links the cellular signaling pathways mediated by Akt and Skp1 in virus-infected cellsA parapoxviral virion protein inhibits NF-κB signaling early in infection.Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain.Recombinant myxoma virus lacking all poxvirus ankyrin-repeat proteins stimulates multiple cellular anti-viral pathways and exhibits a severe decrease in virulenceOrf virus (ORFV) ANK-1 protein mitochondrial localization is mediated by ankyrin repeat motifs.A parapoxviral virion protein targets the retinoblastoma protein to inhibit NF-κB signaling.Myxoma Virus M083 is a virulence factor which mediates systemic dissemination.The kinetoplastid-infecting Bodo saltans virus (BsV), a window into the most abundant giant viruses in the sea.Orientia tsutsugamushi uses two Ank effectors to modulate NF-κB p65 nuclear transport and inhibit NF-κB transcriptional activation.A planarian nidovirus expands the limits of RNA genome size
P2860
Q21558784-1745A168-093F-4663-8E7A-BDD5867EFC46Q23909868-EC394C7A-9E4C-4D77-AFE3-F899C970E973Q24311311-EAB99E9E-5049-4964-9595-3F382E41A5CEQ28083265-D6AECE38-B14E-43CB-91E4-5B7795C42F13Q28237434-36DD89DA-CEF0-4729-BED9-D44F0A769E99Q28391594-1C78107A-FA5F-4513-ABBA-53A6C75B14E1Q33769300-A57C6672-BE7E-4268-94F8-D62CDB14CB28Q34205025-94CF7CAC-DEBA-46BE-90EB-93DE96C82644Q34301763-D0142CBC-6899-4E80-8D7E-6C3D198B49A7Q34457951-5D18FCF3-051A-4A69-A8D4-4CE611EC6DC1Q34742048-9BF5E6C6-D873-470A-8C55-4021E6E1F933Q35101495-0792FA6A-7E05-4548-B8C4-677A2DCFF5FAQ35127337-22320414-6D67-4BF5-B13D-7E9ABEFEC75BQ35232793-247EC6D9-E021-4CBE-A3D4-64158F21EEF8Q36208692-B4609D97-742C-4C28-B39A-EDD461B383D6Q36656176-B15AC914-5B32-4A8D-A30D-7BAFC5F619E6Q36825432-0B56AB42-4829-44F0-BD1F-BB40A8CBC467Q37157179-AA120DFF-C88E-4BD9-B986-386BD53E3CB7Q37224014-3BA02DE3-64D2-4FE1-A8BA-661E3D85A728Q37378752-03BF6A1D-CE30-406D-910C-34F64A6918A1Q37644958-7E3B5F10-878A-4670-9736-F8AE1AA9CAF9Q37887080-3ED4DEC7-0E2A-431F-A558-A1D6E04050B8Q37945194-EEF7686C-2520-472A-AAD9-F1E1B86EEDF8Q37952350-3697E2DE-131A-451D-BA8D-19027745630BQ38062347-4DAA54BD-DF6E-4484-8955-650F828E2360Q38326055-CEF68FAB-2B61-4682-A3CA-9B52ECD0B70CQ38543519-BD3F5250-C682-4CF6-8211-12EEB33A2F2EQ39083904-F8674B56-E7F9-4B96-8A7C-299F5C37715DQ39713080-ADC98A77-8353-4265-9240-6BDC5971B4B6Q39795993-9BFF9AF7-2F47-4634-95C6-58A6DA7DFFB2Q40090682-280E145B-5471-4ED1-9EFC-03E1DAEA31DFQ41842760-0EB0C3AC-631F-4399-B992-27DB27E0E169Q42203408-746FF041-F5D7-4E48-81B3-58C2F270A34EQ42223797-5E71D76F-CFC4-4EED-A18C-9881FA0485EBQ47289904-C3766C75-C740-4B88-AE4A-2085A8C71EF3Q47552286-2EF71F22-E6B1-4AAC-9B6D-898EDD953099Q52340619-5A091A8D-DA74-4A4F-BCED-8D95FEEA39BBQ55075953-4DD8BA4E-19F9-4223-BF99-32BBA6C9B3AEQ58085178-2FEEF044-FB23-483F-867E-4BB3580901F3
P2860
A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
A virulence factor of myxoma v ...... d interferes with inflammation
@en
type
label
A virulence factor of myxoma v ...... d interferes with inflammation
@en
prefLabel
A virulence factor of myxoma v ...... d interferes with inflammation
@en
P2093
P2860
P1433
P1476
A virulence factor of myxoma v ...... d interferes with inflammation
@en
P2093
Béatrice Pignolet
Christelle Camus-Bouclainville
Cédric Filipe
Dorian Counor
Frédérique Messud-Petit
Jacqueline Gelfi
Laurence Fiette
Sophie Bouchiha
P2860
P304
P356
10.1128/JVI.78.5.2510-2516.2004
P407
P577
2004-03-01T00:00:00Z